StockData
Revelation Biosciences, Inc. logo

Revelation Biosciences, Inc. (REVB) bonds

REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.88+0.06 (+1.57%)

Close on Nov 17, 2026Market cap $15.46MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Revelation Biosciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Revelation Biosciences's 10-K/A for the period ended Feb 28, 2021

IssueCoupon
Convertible Debt
Convertible
10.00%

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K/A.

See a number that looks wrong?